112 Public Fund Firms Surveyed 41 A-Share Stocks Last Week; Pharma Sector Leads with Over 100 Visits
During the week of August 3-9, 112 public fund institutions conducted 384 research visits covering 41 A-share stocks across 16 Shenwan industry sectors. The pharmaceutical and biotechnology sector drew the strongest institutional interest, with research visits exceeding 100 and ranking first among all industries. The data, compiled from publicly disclosed research information, highlights the sector's prominence during the period, though specific stocks and institutions were not detailed in the statistics.
During the week of August 3 to August 9, a total of 112 public fund institutions took part in A-share research visit activities, covering 41 individual stocks across 16 Shenwan industries, for a combined 384 visits. The activities spanned a wide range of industries, with statistics based on publicly disclosed research information.
Among these, public fund institutions' interest in the pharmaceutical and biotechnology sector rose markedly, with research visits exceeding 100 and ranking first among all industries. This figure reflects the sector's prominent position in research activity during the week, although specific stocks and institutions were not detailed in the current statistics.